APOE status, age, sex, and AD diagnosis (MCI, mild AD dementia) had no significant effect on relationship between plasma biomarkers (Aβ42/40 ratio, p-tau181), amyloid PET, and clinical endpoints. Here, APOE is linked to Alzheimer disease.